Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease

International Journal of Geriatric Psychiatry

Volumn 19, Issue 7, 2004, Pages 666-672

  Nilsson, Karin ^a   Gustafson, Lars ^a   Hultberg, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Cobalamin; Folate; Homocysteine

Indexed keywords

COBALAMIN; CREATININE; FOLIC ACID; HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLIC ACID DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; RATING SCALE; SCORING SYSTEM; TIME; VITAMIN DEFICIENCY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HOMOCYSTEINE; HUMANS; MALE; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 3242887421     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.1140     Document Type: Article

References (33)

1. Andersson A, Isaksson A, Brattström L, Hultberg B. 1993. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 39: 1590-1597.
2. Berger EY. 1980. A system for rating the severity of senility. J Am Ger Assoc 38: 234-236.
3. Bottiglieri T. 1996. Folate, vitamin B-12 and neuropsychiatric disorders. Nutr Rev 54: 382-390.
4. Brun A, Englund E. 1986. A white-matter disorder in dementia of Alzheimer type. Ann Neurol 19: 253-262.
5. Brun A, Englund E, Gustafson L, et al. 1994. Consensus statement - clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatrtry 57: 416-418.
6. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. 1998. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55: 1449-1455.
7. APA. 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn revised, DSM-III-R. American Psychiatric Association: Washington, DC; 103-107.
8. Englund E, Brun A, Gustafson L. 1989. A white-matter disease in dementia of Alzheimer type. Clinical and neuropathological correlates. Int J Ger Psych 4: 87-102.
9. Erkinjuntti T, Sulkava R. 1991. Diagnosis of multi-infarct dementia. Alzheimer Dis Ass Disord 5: 112-121.
10. Herbert V. 1987. Recommended dietary intakes (RDI) of folate in humans. Am J Clin Nutr 45: 661-670.
11. Hultberg B, Nilsson K, Isaksson A, Gustafson L. 2002. Folate deficiency is a common finding in psychogeriatric patients. Aging Clin Experiment Res 14: 479-484.
12. Hultberg B. 2003. Modulation of extracellular homocysteine concentration in human cell lines. Clin Chim Acta 330: 151-159.
13. Joosten E, Lesaffre E, Riezler R, et al. 1997. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Geront Med Sci 52: M76-M79.
14. Katz S, Ford AB, Moskowitz RW. 1963. Studies of illness in the aged. The index of ADL: a standard measure of biological and psychosocial function. J Am Med Assoc 185: 914-919.
15. Kruman II, Culmsee C, Chan SL, et al. 2000. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitoxicity. J Neurosci 20: 6920-6926.
16. Kruman II, Kumaravel TS, Lohani A, et al. 2002. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22: 1752-1762.
17. Lehmann M, Gottfries CG, Regland B. 1999. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dementia 10: 12-20.
18. McCaddon A, Davies G, Hudson P, Tandy S, Cattel H. 1998. Total serum homocysteine in senile dementia of Alzheimer type. Int J Ger Psych 13: 235-239.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
20. Miller JW, Green R, Ramos MI, et al. 2003. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 78: 441-447.
21. Mudd SH, Levy HL, Skovby F. 1995. Disorders of transsulfuration. In The Metabolic and Molecular Basis of Inherited Disease, 7th edn, Scriver CR, Beaudet AL, Sly WS, Valle D (eds). McGraw-Hill: New York; 1279-1327.
22. Nilsson K, Gustafson L, Fäldt R, Andersson A, Hultberg B. 1994. Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population. Eur J Clin Invest 24: 600-606.
23. Nilsson K, Gustafson L, Fäldt R, et al. 1996. Hyperhomocysteinemia - a common finding in a psychogeriatric population. Eur J Clin Invest 26: 853-859.
24. Nilsson K, Gustafson L, Fäldt R, et al. 1997. Plasma methylmalonic acid in relation to serum cobalamin and plasma homocysteine in a psychogeriatric population and the effect of cobalamin treatment. Int J Ger Psych 12: 62-72.
25. Nilsson K, Gustafson L, Hultberg B. 1999. Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamins and folates in a psychogeriatric population. Dementia 10: 476-482.
26. Nilsson K, Gustafson L, Hultberg B. 2000. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population. Clin Chem 46: 691-696.
27. Nilsson K, Gustafson L, Hultberg B. 2002a. Relation between plasma homocysteine and Alzheimer's disease. Dem Geriatr Cogn Disord 14: 7-12.
28. Nilsson K, Gustafson L, Hultberg B. 2002b. Role of impaired renal function as a cause of elevated plasma homocysteine concentration in psychogeriatric patients. Scand J Clin Lab Invest 62: 385-390.
29. Refsum H, Ueland PM, Nygård O, Vollset SE. 1998. Homocysteine and cardiovascular disease. Annu Rev Med 49: 31-62.
30. Schanker G, Aschner M. 2001. Identification and characterization of uptake systems for cystine, and cysteine in cultured astrocytes and neurons: evidence for methylmercury-targeted disruption of astrocyte transport. J Neurosci Res 66: 998-1002.
31. Seshadri S, Beiser A, Selhub J, et al. 2002. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346: 476-483.
32. Wallin A, Blennow K, Gottfries CG, Långström G, Uhlemann C. 1989. White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia. Acta Neurol Scand 80: 518-523.
33. Zieminska E, Stafiej A, Lazarewicz JW. 2003. Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones. Neurochem Int 43: 481-492.